Lobule type and subsequent breast cancer risk: results from the Nurses' Health Studies
- PMID: 19170235
- PMCID: PMC2661011
- DOI: 10.1002/cncr.24167
Lobule type and subsequent breast cancer risk: results from the Nurses' Health Studies
Abstract
Background: Lobules in normal breast tissue can be classified based on their degree of development, which may affect their susceptibility to carcinogenesis. However, few epidemiologic studies to date have addressed this.
Methods: The authors examined the association between lobule type and subsequent breast cancer risk in a nested case-control study of benign breast disease (BBD) and breast cancer within the Nurses' Health Studies (200 cases, 915 controls). Benign breast biopsy slides were reviewed by pathologists, and normal terminal duct lobular units were classified as having no type 1 lobules, mixed lobule types, or predominant type 1 and no type 3 lobules. Logistic regression was used to compute odds ratios (ORs) and 95% confidence intervals (CIs) for the association between lobule type and breast cancer risk.
Results: Women with predominant type 1 and no type 3 lobules (54 cases, 321 controls) had a decreased risk of breast cancer compared with those with no type 1 lobules or mixed lobule types (OR=0.63; 95% CI, 0.44-0.91), although this was attenuated after adjustment for histologic category of BBD (OR=0.71; 95% CI, 0.49-1.02). Having predominant type 1 lobules and no type 3 lobules was associated with a similar risk reduction for all categories of BBD (nonproliferative: OR=0.73 [95% CI, 0.36-1.50]; proliferative without atypia: OR=0.80 [95% CI, 0.47-1.35]; and atypical hyperplasia: OR=0.61 [95% CI, 0.28-1.35]).
Conclusions: These results provided preliminary evidence that lobule type may be an important marker of breast cancer risk in women with BBD.
(c) 2009 American Cancer Society
Similar articles
-
Insulin-like growth factor-1, insulin-like growth factor binding protein-3 and lobule type in the Nurses' Health Study II.Breast Cancer Res. 2012 Mar 13;14(2):R44. doi: 10.1186/bcr3141. Breast Cancer Res. 2012. PMID: 22414675 Free PMC article.
-
Columnar cell lesions and subsequent breast cancer risk: a nested case-control study.Breast Cancer Res. 2010;12(4):R61. doi: 10.1186/bcr2624. Epub 2010 Aug 6. Breast Cancer Res. 2010. PMID: 20691043 Free PMC article.
-
The influence of family history on breast cancer risk in women with biopsy-confirmed benign breast disease: results from the Nurses' Health Study.Cancer. 2006 Sep 15;107(6):1240-7. doi: 10.1002/cncr.22136. Cancer. 2006. PMID: 16902983
-
Diagnosis and management of benign, atypical, and indeterminate breast lesions detected on core needle biopsy.Mayo Clin Proc. 2014 Apr;89(4):536-47. doi: 10.1016/j.mayocp.2014.02.004. Mayo Clin Proc. 2014. PMID: 24684875 Review.
-
Updates in the Surgical Management of Benign and High-Risk Breast Lesions.Clin Breast Cancer. 2024 Jun;24(4):278-285. doi: 10.1016/j.clbc.2023.12.008. Epub 2023 Dec 21. Clin Breast Cancer. 2024. PMID: 38171944 Review.
Cited by
-
Deep Learning Image Analysis of Benign Breast Disease to Identify Subsequent Risk of Breast Cancer.JNCI Cancer Spectr. 2021 Jan 11;5(1):pkaa119. doi: 10.1093/jncics/pkaa119. eCollection 2021 Feb. JNCI Cancer Spectr. 2021. PMID: 33644680 Free PMC article.
-
Atypical hyperplasia of the breast--risk assessment and management options.N Engl J Med. 2015 Jan 1;372(1):78-89. doi: 10.1056/NEJMsr1407164. N Engl J Med. 2015. PMID: 25551530 Free PMC article. No abstract available.
-
Association between breast cancer genetic susceptibility variants and terminal duct lobular unit involution of the breast.Int J Cancer. 2017 Feb 15;140(4):825-832. doi: 10.1002/ijc.30512. Epub 2016 Nov 18. Int J Cancer. 2017. PMID: 27859137 Free PMC article.
-
Histopathological Features of Non-Neoplastic Breast Parenchyma Do Not Predict BRCA Mutation Status of Patients with Invasive Breast Cancer.Biomark Cancer. 2015 Aug 18;7:39-49. doi: 10.4137/BIC.S29716. eCollection 2015. Biomark Cancer. 2015. PMID: 26327783 Free PMC article.
-
Relationship between breast tissue involution and breast cancer.Front Oncol. 2025 Apr 7;15:1420350. doi: 10.3389/fonc.2025.1420350. eCollection 2025. Front Oncol. 2025. PMID: 40260293 Free PMC article. Review.
References
-
- Russo J, Russo IH. Toward a physiological approach to breast cancer prevention. Cancer Epidemiol Biomarkers Prev. 1994;3(4):353–64. - PubMed
-
- Russo J, Gusterson BA, Rogers AE, Russo IH, Wellings SR, van Zwieten MJ. Comparative study of human and rat mammary tumorigenesis. Lab Invest. 1990;62(3):244–78. - PubMed
-
- Russo J, Tay LK, Russo IH. Differentiation of the mammary gland and susceptibility to carcinogenesis. Breast Cancer Res Treat. 1982;2(1):5–73. - PubMed
-
- Ramakrishnan R, Gann PH, Wiley EL, Khurana KK, Khan SA. Normal breast lobular architecture in breast biopsy samples from breast cancer cases and benign disease controls. Breast Cancer Res Treat. 2004;86(3):259–68. - PubMed
-
- Henson DE, Tarone RE. On the possible role of involution in the natural history of breast cancer. Cancer. 1993;71(6 Suppl):2154–6. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical